Advertisement

Topics

Dainippon Pharmaceutical Company Limited Company Profile

19:23 EST 22nd January 2017 | BioPortfolio

Antibiotics Diagnostics Veterinary

Location

6-8 Dosho-machi 2-chome Chuo-ku
Osaka
Osaka
541
Japan

Contact

Phone: 81 6 6203 5321
Fax: 81 6 203 6581


News Articles [1859 Associated News Articles listed on BioPortfolio]

Cambridge Combinatorial Completes Collaboration With Dainippon Pharmaceutical; Expands Lab Facilities

Cambridge Combinatorial Ltd., a wholly owned subsidiary of Oxford Molecular Group, has completed delivery of library compounds in their collaboration with Dainippon Pharmaceutical Co. Ltd., a Japanese...

Sumitomo Dainippon makes US acquisition

Sumitomo Dainippon Pharma has made its first venture into the M&A arena this year, with the proposed…

Sharp Edge Labs Enters into Drug Discovery Collaboration with Sumitomo Dainippon Pharma

PITTSBURGH, Jan. 3, 2017 /PRNewswire/ -- Sharp Edge Labs, Inc., a drug discovery and development company focused on diseases involving defective protein trafficking, today announced that it has entere...

Hutchison China Meditech Limited: Blocklisting Six Monthly Return

HONG KONG, CHINA -- (Marketwired) -- 12/29/16 -- Hutchison China Meditech Limited (NASDAQ: HCM) (AIM: HCM) Blocklisting Six Monthly Return London: Thursday, December 29, 2016: Hutchison China MediT...

Aoxing Pharmaceutical Company, Inc. Formerly China Aoxing Pharmaceutical Company, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Sumitomo Dainippon acquires Tolero for $200mm cash plus earn-outs

Sumitomo Dainippon Pharma Co. Ltd. is acquiring privately held oncology firm Tolero Pharmaceuticals Inc. for $200mm in cash up front. The deal also includes up to $430mm in earn-outs based on developm...

La Jolla Pharmaceutical Company Receives Positive Opinion from European Orphan Committee for LJPC-401

La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from ...

La Jolla Pharmaceutical Company Announces Agreement with European Medicines Agency on Pivotal Study of LJPC-401

-Conference Call at 9:00 AM Eastern Time on Thursday, September 8, 2016 La Jolla Pharmaceutical Company (Nasdaq: LJPC) (the Company or La Jolla), a leader in the development of innovative therapie...

Drugs and Medications [0 Results]

None

Clinical Trials [36 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care Service in Diabetes

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation

The aim of this prospective randomized double-blind study was to compare the efficacy of new pharmaceutical composition containing botulinum toxin injection in epicardial fat pads for prev...

Pharmacotherapy Follow-up in Older HIV-infected Patients

Cardiovascular diseases (CVD) are the main cause of death in Spain. In HIV patients, the uncontrolled viral replication, antiretroviral therapy (ART) and coinfections contribute to develop...

Randomized Crossover Trial for the Evaluation of the Possible Effects in the Intestine of Two Different Pharmaceutical Forms of L - Thyroxine in Patients With Primary Acquired Hypothyroidism

Thyroid disorders, in particular hypothyroidism, are associated with gastrointestinal impairment, such as celiac disease. A study reported an increased prevalence of celiac disease in a la...

Bioequivalence Study of Daclatasvir From Prodactariv 60 mg Film Coated Tablets (International Drug Agency for Pharmaceutical Industry (IDI), Egypt) and Clatazev 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Prodactariv 60 mg F.C.T (International Drug Agency for Pha...

Companies [28 Associated Companies listed on BioPortfolio]

Starpharma Holdings Ltd

Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY), located in Melbourne Australia, is an ASX 300 company and is a world leader in the development of dendrimer products for pharma...

Espero Pharmaceuticals, Inc.

Dainippon Sumitomo Pharma Co., Ltd.

Dainippon Sumitomo Pharma Co., Ltd., (DSP), is a top-ten listed pharmaceutical company in Japan with a diverse portfolio of pharmaceutical, animal health and food and specialty products. DSP's strong...

Shinkowa Pharmaceutical Co., Ltd.

Based in Tokyo, Japan, Shinkowa Pharmaceutical Co., Ltd. (http://shinkowapharma.com/) is a pharmaceutical company that has developed and sells dietary supplements and cosmetics in...

Dainippon Sumitomo Pharma America, Inc.

Dainippon Sumitomo Pharma America, Inc. (DSPA) located in Fort Lee, N.J., is a subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP). On April 1, 2010, DSP's two North American operations - DSPA and...

More Information about "Dainippon Pharmaceutical Company Limited" on BioPortfolio

We have published hundreds of Dainippon Pharmaceutical Company Limited news stories on BioPortfolio along with dozens of Dainippon Pharmaceutical Company Limited Clinical Trials and PubMed Articles about Dainippon Pharmaceutical Company Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Dainippon Pharmaceutical Company Limited Companies in our database. You can also find out about relevant Dainippon Pharmaceutical Company Limited Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record